Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- Check5 days agoChange DetectedThe page now features a Locations section listing Kansas as a site, and the revision updated to v3.3.3; the old Kansas Locations section and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1, a minor update in the footer that does not alter study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed; this appears to be a site/build update that does not alter the study details, eligibility criteria, or data shown on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe government funding/operating status notice was removed from the page. This change does not affect the study details, eligibility criteria, or contacts listed.SummaryDifference0.5%

- Check55 days agoChange DetectedThe page shows the same study details with a redesigned layout; core information such as the title, conditions, intervention, eligibility criteria, and key dates remains unchanged.SummaryDifference0.5%

- Check84 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference6%

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.